Boston Scientific (BSX) Tax Provisions (2009 - 2026)

Boston Scientific has disclosed Tax Provisions across 18 years of filings, most recently posting -$176.0 million for Q1 2026.

• Tax Provisions for Q1 2026 came in at -$176.0 million, down 232.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $183.0 million (down 59.69% YoY), and the FY2025 annual result was $493.0 million, up 13.07% from the prior year.
• Tax Provisions came in at -$176.0 million for Q1 2026 at Boston Scientific, down from $30.0 million in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $255.0 million in Q4 2022 to a low of -$176.0 million in Q1 2026.
• The 5-year median for Tax Provisions is $105.0 million (2023), against an average of $93.4 million.
• Across the five-year window, Tax Provisions jumped 2200.0% in 2024 and slumped 232.33% in 2026, its largest moves.
• Boston Scientific's Tax Provisions stood at $255.0 million in 2022, then sank by 99.61% to $1.0 million in 2023, then surged by 2200.0% to $23.0 million in 2024, then jumped by 30.43% to $30.0 million in 2025, then sank by 686.67% to -$176.0 million in 2026.
• The last three Tax Provisions figures came in at -$176.0 million (Q1 2026), $30.0 million (Q4 2025), and $183.0 million (Q3 2025), per Business Quant data.